IFNA2 Antikörper
(5 Referenzen)-
- Target Alle IFNA2 Antikörper anzeigen
- IFNA2 (Interferon, alpha 2 (IFNA2))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser IFNA2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, ELISpot
- Spezifität
- Native and recombinant human IFN-α subtypes 2a, 2b, 2c
- Aufreinigung
- Purified from in vitro cultures by protein G affinity chromatography.
- Sterilität
- 0.2 μm filtered
- Immunogen
- Recombinant human IFN-alpha 2c
- Klon
- MT1
- Isotyp
- IgG1
- Top Product
- Discover our top product IFNA2 Primärantikörper
-
anti-Interferon, alpha 2 (IFNA2) (AA 24-188) antibody
IFNA2 Reaktivität: Human ELISA, WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) (AA 24-188) antibodyIFNA2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) (C-Term) antibodyIFNA2 Reaktivität: Human WB, IF, ICC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) (AA 1-188) antibodyIFNA2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) (AA 24-188) antibodyIFNA2 Reaktivität: Human ELISA, WB Wirt: Maus Monoclonal 1F8 unconjugated
anti-Interferon, alpha 2 (IFNA2) (AA 24-188) antibodyIFNA2 Reaktivität: Human ELISA, WB Wirt: Maus Monoclonal 2B1 unconjugated
anti-Interferon, alpha 2 (IFNA2) (N-Term) antibodyIFNA2 Reaktivität: Human ELISA, WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) (AA 24-192) antibodyIFNA2 Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) (AA 24-188) antibodyIFNA2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal D4 unconjugated
anti-Interferon, alpha 2 (IFNA2) antibodyIFNA2 Reaktivität: Human ELISA, WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- supplied at 1 mg/mL in PBS with 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.
- Haltbarkeit
- 18 months
-
-
: "Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer." in: Scientific reports, Vol. 8, Issue 1, pp. 12954, (2019) (PubMed).
: "Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Issue 3, pp. E478-E487, (2018) (PubMed).
: "An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous Administration." in: Biomacromolecules, Vol. 18, Issue 9, pp. 2866-2875, (2018) (PubMed).
: "Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes." in: Nutrients, Vol. 9, Issue 9, (2018) (PubMed).
: "Human monocytes represent a competitive source of interferon-alpha in peripheral blood." in: Clinical immunology (Orlando, Fla.), Vol. 127, Issue 2, pp. 252-64, (2008) (PubMed).
-
: "Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer." in: Scientific reports, Vol. 8, Issue 1, pp. 12954, (2019) (PubMed).
-
- Target
- IFNA2 (Interferon, alpha 2 (IFNA2))
- Andere Bezeichnung
- IFNA2 (IFNA2 Produkte)
- Gen-ID
- 3440
- Pathways
- JAK-STAT Signalweg, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Hepatitis C
-
